The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led recall for Imatinib 400mg Capsules.
Cipla (EU) Limited has informed the MHRA that there is an error on the Patient Information Leaflet (PIL) for Imatinib 400mg Capsules: the dosage information for the indication CML is incorrect.
Further details of the alert, including the affected batch, and action to take are available on the MHRA website.
Want the latest pharmacy news and updates straight to your inbox?
Sign up to our regular newsletter for the latest guidance, news, events and CPD opportunities.
Sign Up
Become an RPS Member today and save up to £26 by choosing annual Direct DebitOR spread the cost by switching to monthly payments.
RPS membership is better value than ever in 2024 - join today!
BECOME A MEMBER TODAY